HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Simon Ducharme Selected Research
Simon Ducharme Research Topics
Disease
29
Frontotemporal Dementia (Semantic Dementia)
04/2024 - 01/2018
9
Disease Progression
05/2024 - 12/2019
9
Alzheimer Disease (Alzheimer's Disease)
12/2023 - 07/2013
7
Atrophy
01/2024 - 01/2018
5
Dementia (Dementias)
05/2024 - 07/2013
5
Mental Disorders (Mental Disorder)
03/2024 - 01/2019
3
Cognitive Dysfunction
05/2024 - 01/2019
3
Parkinson Disease (Parkinson's Disease)
01/2024 - 01/2011
2
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
12/2023 - 01/2022
2
Gliosis
01/2022 - 01/2020
2
Psychotic Disorders (Schizoaffective Disorder)
06/2019 - 01/2017
1
Prodromal Symptoms
01/2023
1
Sleep Apnea Syndromes (Sleep Apnea)
10/2022
1
Neuroinflammatory Diseases
09/2022
1
Tauopathies
01/2022
1
COVID-19
01/2022
1
Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2022
1
Cerebral Cortical Thinning
01/2021
1
Neurocognitive Disorders (Clerambault Syndrome)
01/2021
1
Kufor-Rakeb syndrome
06/2019
1
Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
01/2019
1
Nervous System Diseases (Neurological Disorders)
01/2019
1
Major Depressive Disorder (Major Depressive Disorders)
01/2019
1
Seizures (Absence Seizure)
01/2017
1
Status Epilepticus (Complex Partial Status Epilepticus)
01/2017
1
Epilepsy (Aura)
01/2017
1
Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
07/2013
1
Opioid-Related Disorders (Opiate Addiction)
01/2012
1
Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2012
Drug/Important Bio-Agent (IBA)
24
Biomarkers (Surrogate Marker)
IBA
05/2024 - 01/2012
4
Tuberculin (PPD)
IBA
03/2024 - 01/2019
4
Progranulins
IBA
01/2023 - 01/2019
4
Granulins
IBA
01/2022 - 01/2021
3
Amyloid (Amyloid Fibrils)
IBA
05/2024 - 07/2013
3
Proteins (Proteins, Gene)
FDA Link
11/2023 - 11/2021
2
Indicators and Reagents (Reagents)
IBA
05/2024 - 01/2024
2
Tablets
IBA
01/2024 - 01/2023
2
Antisense Oligonucleotides
IBA
10/2023 - 06/2023
2
Microtubule-Associated Proteins (Microtubule-Associated Protein 2)
IBA
01/2023 - 08/2022
2
Complement System Proteins (Complement)
IBA
09/2022 - 01/2020
2
Glial Fibrillary Acidic Protein
IBA
01/2022 - 01/2020
2
neuronal pentraxin
IBA
01/2022 - 01/2020
1
2- (3,4- dichlorophenyl)- N- methyl- N- (1- (3- isothiocyanatophenyl)- 2- (1- pyrrolidinyl)ethyl)acetamide
IBA
12/2023
1
Blood Proteins (Serum Proteins)
IBA
11/2023
1
Acetylcholine (Acetylcholine Chloride)
FDA Link
01/2023
1
Dopamine (Intropin)
FDA Link
Generic
01/2023
1
Serotonin (5 Hydroxytryptamine)
IBA
01/2023
1
Neurotransmitter Agents (Neurotransmitter)
IBA
01/2023
1
Hydrocortisone (Cortisol)
FDA Link
Generic
01/2022
1
Suspensions
IBA
11/2021
1
Aripiprazole (Abilify)
FDA Link
06/2019
1
Protons (Proton)
IBA
01/2018
1
Antipsychotic Agents (Antipsychotics)
IBA
01/2017
1
Clozapine (Clozaril)
FDA Link
Generic
01/2017
1
2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)
IBA
07/2013
1
Naloxone Drug Combination Buprenorphine
FDA Link
01/2012
1
Buprenorphine (Subutex)
FDA Link
Generic
01/2012
Therapy/Procedure
2
Deep Brain Stimulation
01/2019 - 01/2011
1
Neurosurgical Procedures
01/2019